This peptide is widely used in clinical research to study the effects of GLP-1 receptor agonists in diabetes therapy , weight management , and metabolic disorders
Ideal for those with visible dark spots, uneven tone, or early signs of aging who seek advanced brightening and firming without compromise
Therapeutic strategies such as probiotics, prebiotics, synbiotics, and fecal microbiota transplantation may help restore microbial balance and alleviate symptoms of these disorders
Potential indications include: Chronic weight management Type 2 diabetes Metabolic dysfunction-associated steatohepatitis (MASH / NASH) Other metabolic diseases Yao Pharma will continue its ongoing Phase 1 trial in Australia , after which Pfizer takes full control of global development and commercialization
[Experimental study of the effects of metabolic drugs on exercise tolerance]